ormulation technology for stabilized lipid-based nanoparticles (LNPs)

This was largely made possible by major advances in the formulation technology for stabilized lipid-based nanoparticles (LNPs). Design of the cationic ionizable lipids, which are a key component of the LNP formulations, with an acid dissociation constant (pKa) close to the early endosomal pH, would not only ensure effective encapsulation of mRNA into the stabilized lipoplexes within the LNPs, but also its subsequent endosomal release into the cytoplasm after endocytosis.
Unlike other gene therapy modalities, which require nuclear delivery, the site of action for exogenous mRNA vaccines is the cytosol where they get translated into antigenic proteins and thereby elicit an immune response. LNPs also protect the mRNA against enzymatic degradation by the omnipresent ribonucleases (RNases). Cationic nano emulsion (CNE) is also explored as an alternative and relatively thermostable mRNA vaccine delivery vehicle.
In this review, we have summarized the various delivery strategies explored for more details joplink Recombinant Human Serine  mRNA vaccines, including naked mRNA injection; ex vivo loading of dendritic cells; CNE; cationic peptides; cationic polymers, and finally the clinically successful COVID-19 LNP vaccines  (Pfizer/BioNTech and Moderna vaccines)-their components, design principles, formulation parameter optimization, and stabilization challenges. Despite the clinical success of LNP-mRNA vaccine formulations, there is a specific need to enhance their storage stability above 0 °C for these lifesaving vaccines to reach the developing.

Understanding the role of microperimetry in glaucoma

The present narrative review attempts to provide an overview on the use of microperimetry or fundus-driven perimetry in glaucoma, considering the clinical use, the different strategies and limits compared to standard automated perimetry.
 An electronic database (PubMed and Medline) search was performed of articles of any type published in the English language between 1998 and 2020 with a combination of the following terms: microperimetry, glaucoma, primary open-angle chronic glaucoma, visual field, Humphrey visual field, fundus automated perimetry.
All the original articles, case reports, and short series analyzed were included in the present review, offering an excursus on the strengths and limitations characterizing the use of microperimetry in glaucomatous patients. The characteristics of a recently introduced fundus-driven perimetry Compass (CMP; Centervue, Padua, Italy) were also included.
Although there remain several contradictions regarding routine use of microperimetry and the restricted research on this topic limits our ability to draw firm conclusions, microperimetry may be preferable in cases of localized retinal nerve fiber layer defects in patients with primary open-angle glaucoma and normal visual field. However, standard automated perimetry remains the gold standard for monitoring glaucoma, especially in patients with diffuse retinal nerve fiber layer impairment and visual field defects. The newly introduced Compass device can potentially provide a more accurate structural-functional evaluation than standard automated perimetry and can therefore produce superior testing reliability.

Ligand-Directed GPCR Antibody Discovery

Developing affinity reagents recognizing and modulating G-protein coupled receptors (GPCR) function by traditional animal immunization or in vitro screening methods is challenging. Some anti-GPCR antibodies exist on the market, but the success rate of development is still poor compared with antibodies targeting soluble or peripherally anchored proteins.

  • More importantly, most of these antibodies do not modulate GPCR function. The current pipeline for antibody development primarily screens for overall affinity rather than functional epitope recognition. We developed a new strategy utilizing natural ligand affinity to generate a library of antibody variants with an inherent bias toward the active site of the GPCR.
  • Instead of using phage libraries displaying antibodies with random CDR sequences at polymorphism sites observed in natural immune repertoire sequences, we generated focused antibody libraries with a natural ligand encoded within or conjugated to one of the CDRs or the N-terminus.
  • To tailor antibody binding to the active site, we limited the sequence randomization of the antibody in regions holstering the ligand while leaving the ligand-carrying part unaltered in the first round of randomization. With hits from the successful first round, the second round of randomization of the ligand-carrying part was then performed to eliminate the bias of the ligand.
  • Based on our results on three different GPCR targets, the proposed pipeline will enable the rapid generation of functional antibodies (both agonists and antagonists) against high-value targets with poor function epitope exposures including GPCR, channels, transporters as well as cell surface targets whose binding site is heavily masked by glycosylation.

endohedral trihedral metallo-borospherenes with spherical aromaticity

It is well-known that transition-metal-doping induces dramatic changes in the structures and bonding of small boron clusters, as demonstrated by the newly observed perfect inverse sandwich D8h [La(η8-B8)La] and D9h [La(η9-B9)La]. Based on extensive global minimum searches and first-principles theory calculations, we predict herein the possibility of perfect endohedral trihedral metallo-borospherene D3h La@[La5&B30] (1, 3A’1) and its monoanion Cs La@[La5&B30] (2, 2A’) and dianion D3h La@[La5&B30]2- (3, 1A’1).

These La-doped boron clusters are composed of three inverse sandwich La(η8-B8)La on the waist and two inverse sandwich La(η9-B9)La on the top and bottom which share one apex La atom at the center and six periphery B2 units between neighboring η8-B8 and η9-B9 rings, with three octo-coordinate La atoms and two nona-coordinate La atoms as integrated parts of the cage surface.

Detailed adaptive natural density partitioning (AdNDP) and iso-chemical shielding surface (ICSS) analyses indicate that La@[La5&B30]0/-/2- (1/2/3) are spherically aromatic in nature. The one-dimensional nanowire La4B21 (4, Pm) constructed from D3h La@[La5&B30] (1) along the C3 axis of the system appears to be metallic. The IR and Raman spectra of La@[La5&B30] (1) and photoelectron spectroscopy of the slightly distorted Cs La@[La5&B30] (2) are theoretically simulated to facilitate their spectroscopic characterizations.

Towards the saving of global rainforests

Rainforests are the Earth’s largest terrestrial carbon sinks and are rapidly shrinking due to unprecedented human impact, especially tropical rainforests, which host ~50% of global biodiversity. Understanding what makes rainforests resilient on a long-term basis is key to preserving global rainforests and their ecological services.
Here, using estimates of rates-of-change (RoC) in fossil pollen records, an indicator for temporal compositional change (turnover) in vegetation, we show that accelerating trends in global rainforest changes (increasing RoC/turnover) during the last 12,000 years were mainly driven by intensive agricultural practices, and the highly diverse and productive tropical rainforests were the most impacted.
Management/conservation strategies aimed at the effective management of human impact will help promote rainforest health and diversity and increase resilience under projected climate change.

Recombinant Human Serine racemase

0.02mg(E-Coli) 320 EUR

Recombinant Human Serine racemase

0.1mg(E-Coli) 520 EUR

Recombinant Human Serine racemase

1mg(E-Coli) 1925 EUR

Recombinant Human Serine racemase

5x1mg(E-Coli) 8405 EUR

Recombinant Human Serine Racemase

0.001mg 240 EUR

Recombinant Human Serine Racemase

0.005mg 310 EUR

Recombinant Human Serine Racemase

0.05mg 1260 EUR

Recombinant Human Serine Racemase

5x0.05mg 5345 EUR

Recombinant Human Serine racemase

0.05mg 405 EUR

Recombinant Human Serine racemase

0.2mg 760 EUR

Fusogenic Viral Protein-Based Near-Infrared Active Nanocarriers for Biomedical

As a proof of concept, we bioengineered the vesicular stomatitis virus glycoprotein (VSV-G)-based near-infrared (NIR) active viral nanoconstructs (NAVNs) encapsulating indocyanine green dye (ICG) for NIR bioimaging.

NAVNs are spherical in size and have the intrinsic cellular-fusogenic properties of VSV-G. Further, the NIR imaging displaying higher fluorescence intensity in NAVNs treated cells suggests enhanced cellular uptake and delivery of ICG by NAVNs compared to the free form of ICG and for more information than visit joplink recombinant human to highlights. The overall study highlights the effectiveness of VSV-G-based VNPs as an efficient delivery system for NIR fluorescence imaging.

Phosphorylation of Trans-active response DNA binding protein-of 43 kDa promotes its cytoplasmic aggregation and modulates its function in tau mRNA stability and exon 10 alternative splicing

Trans-active response DNA-binding protein of 43 kDa (TDP-43) promotes tau mRNA instability and tau exon 10 inclusion. Aggregation of phosphorylated TDP-43 is associated with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). CK1ε phosphorylates TDP-43 at multiple sites, enhances its cytoplasmic aggregation and modu-lates its function in tau mRNA processing.

To determine roles of TDP-43 site-specific phos-phorylation in its localization, aggregation, and function in tau mRNA processing, TDP-43 was mutated to alanine or aspartic acid at Ser379, Ser403/404, or Ser409/410 to block or mimic phosphorylation. Site-specific phosphorylation of TDP-43 and its mutants by CK1ε was studied in vitro and in cultured cells. Cytoplasmic and nuclear TDP-43 and phospho-TDP-43 were analyzed by Western blots.

Aggregation of TDP-43 was assessed by immunostaining and level of RIPA-insoluble TDP-43. GFP tailed with tau 3′-UTR and mini-tau gene pCI/SI9-LI10 were used to study tau mRNA stability and alternative splicing of tau exon 10. We found that phospho-blocking mutations of TDP-43 at Ser379, Ser403/404, or Ser409/410 were not effectively phosphorylated by CK1ε.

Compared with TDP-43, higher level of phosphorylated TDP-43 in the cytoplasm was observed. Phospho-mimicking mutations at these sites enhanced cytoplasmic aggregation of TDP-43. GFP expression was not inhibited by phospho-blocking mutants of TDP-43, but tau exon 10 inclusion was further enhanced by phospho-blocking mutations at Ser379 and Ser403/404. Phosphorylation of TDP-43 at Ser379, Ser 403/404 or Ser409/410 primes its phosphorylation by CK1ε, promotes TDP-43 cytoplasmic aggregation and modulates its function in tau mRNA processing in site-specific manner.

Oncogenic mutations Q61L and Q61H confer active form-like structural features to the inactive state (state 1) conformation of H-Ras protein

GTP-bound forms of Ras proteins (Ras•GTP) assume two interconverting conformations, “inactive” state 1 and “active” state 2. Our previous study on the crystal structure of the state 1 conformation of H-Ras in complex with guanosine 5′-(β, γ-imido)triphosphate (GppNHp) indicated that state 1 is stabilized by intramolecular hydrogen-bonding interactions formed by Gln61. Since Ras are constitutively activated by substitution mutations of Gln61, here we determine crystal structures of the state 1 conformation of H-Ras•GppNHp carrying representative mutations Q61L and Q61H to observe the effect of the mutations.

The results show that these mutations alter the mode of hydrogen-bonding interactions of the residue 61 with Switch II residues and induce conformational destabilization of the neighboring regions. In particular, Q61L mutation results in acquirement of state 2-like structural features. Moreover, the mutations are likely to impair an intramolecular structural communication between Switch I and Switch II. Molecular dynamics simulations starting from these structures support the above observations. These findings may give a new insight into the molecular mechanism underlying the aberrant activation of the Gln61 mutants.

Effect of Active Coatings Containing Lippa citriodora Kunth. Essential Oil on Bacterial Diversity and Myofibrillar Proteins Degradation in Refrigerated Large Yellow Croaker

The research evaluated the effects of locust bean gum (LBG) and sodium alginate (SA) active coatings containing 0.15, 0.30 or 0.60% lemon verbena (Lippa citriodora Kunth.) essential oil (LVEO) on the bacterial diversity and myofibrillar proteins (MPs) of large yellow croaker during refrigerated storage at 4 °C for 18 days. Variability in the dominant bacterial community in different samples on the 0, 9th and 18th day was observed.

. Pseudomonas and Shewanella were the two major genera identified during refrigerated storage. At the beginning, the richness of Pseudomonas was about 37.31% and increased for control (CK) samples during refrigerated storage, however, the LVEO-treated samples increased sharply from day 0 to the 9th day and then decreased.

LBG-SA coatings containing LVEO treatments significantly delayed MPs oxidation by retarding the formation of free carbonyl compounds and maintaining higher sulfhydryl content, higher Ca2+-ATPase activity, better organized secondary (higher contents of α-helix and β-sheet) and tertiary structures during refrigerated storage.

The transmission electron microscope (TEM) images showed that the integrity of the sarcomere was damaged; the boundaries of the H-, A-, and I-bands, Z-disk, and M-line were fuzzy in the CK samples at the end of storage. However, the LVEO-treated samples were still regular in appearance with distinct dark A-bands, light I-bands, and Z-disk. In brief, LBG-SA active coatings containing LVEO treatments suggested a feasible method for protecting the MPs of large yellow croaker during refrigerated storage.

Ribosome-Inactivating Proteins of Bougainvillea glabra Uncovered Polymorphism and Active Site Divergence

Ribosome-inactivating proteins (RIPs) are toxic proteins that can inhibit protein synthesis. RIPs purified from Bougainvillea have low nonspecific toxicity, showing promise for processing applications in the agricultural and medical fields. However, systematic research on the polymorphism of Bougainvillea RIPs is lacking, and it is worth exploring whether different isoforms differ in their active characteristics. The transcriptional and translational expression of type I RIPs in Bougainvillea glabra leaves was investigated in this study. Seven RIPs exhibited seasonal variation at both the mRNA and protein levels.

The isoforms BI4 and BI6 showed the highest transcriptional expression in both the summer and autumn samples. Interestingly, BI6 was not detected in the protein level in any of the samples. However, the bioinformatics analysis showed that RIPs derived from the same species were gathered in a different cluster, and that the active sites changed among the isoforms during evolution.

The significant discrepancy in Bougainvillea RIPs mainly locates at both termini of the amino acid sequence, particularly at the C terminus. Post-translational modifications may also exist in Bougainvillea RIPs. It is concluded that the reason for the polymorphism of Bougainvillea RIPs may be that these proteins are encoded by multiple genes due to genetic processes such as gene duplication and mutation. According to the results of sequence analysis, the possible functional differences of B. glabra RIP isoforms are discussed with regard to the observed discrepancy in both active sites and structures.

 

Recombinant Human C5AR1

0.05mg 345 EUR

Recombinant Human C5AR1

0.2mg 635 EUR

Recombinant Human C5AR1

1mg 1800 EUR

Recombinant Human C5AR1

5x1mg 6955 EUR

C5AR1 Recombinant Protein (Human)

100 ug Ask for price

Recombinant Human C5AR1, His-tagged

25ug 255.2 EUR

C5R1 (C5AR1) (NM_001736) Human Recombinant Protein

20 ug 785.42 EUR

Recombinant Human C5AR1 protein, C-His Tag(VLPs)

20µg 720 EUR

Recombinant Human C5a anaphylatoxin chemotactic receptor (C5AR1)

0.02mg 1665 EUR

Recombinant Human C5a anaphylatoxin chemotactic receptor (C5AR1)

0.1mg 2625 EUR

Resolving the formidable barrier of oxygen transferring rate (OTR) in ultrahigh-titer bioconversion/biocatalysis by a sealed-oxygen supply biotechnology (SOS).

Resolving the formidable barrier of oxygen transferring rate (OTR) in ultrahigh-titer bioconversion/biocatalysis by a sealed-oxygen supply biotechnology (SOS).

The vital situation within the competitiveness between bioengineering and chemical engineering is the merchandise titer and the amount productiveness. Essentially the most direct and efficient method normally employs high-density biocatalyst, whereas the weakened mass switch and evoked foam downside accompany ultrahigh-density biocatalyst loading and substrate/product titer.

In high-density obligate cardio bioconversion, oxygen as electron acceptor is a speed-limiting step in bioprocesses, however ample oxygen provide will result in the foaming which ends up in a big discount in oxygen utilization and the usage of further defoamers. On this examine, we designed a novel sealed-oxygen provide (SOS) biotechnology to resolve the formidable barrier of oxygen transferring price (OTR), for bio-based fuels and chemical manufacturing course of.

Outcomes

Based mostly on systemic evaluation of whole-cell catalysis in Gluconobacter oxydans, a novel sealed-oxygen provide expertise was neatly designed and experimentally carried out for biocatalytic oxidation of alcohols, sugars and so forth. By a easy operation ability of computerized on-line provide of oxygen in a sealed stirring tank bioreactor of SOS, OTR barrier and foaming downside was resolved with nice ease.

We lastly obtained ultrahigh-titer merchandise of xylonic acid (XA), 3-hydroxypropionic acid (3-HPA), and erythrulose at 588.four g/L, 69.four g/L, and 364.7 g/L, respectively. Furthermore, the amount productiveness of three chemical merchandise was improved by 150-250% in contrast with regular biotechnology. This SOS expertise offers a promising method to advertise bioengineering competitiveness and benefits over chemical engineering.

SOS expertise was demonstrated as an financial and universally relevant method to bio-based fuels and chemical substances manufacturing by whole-cell catalysis. The novel expertise drastically promotes the competitiveness of bioengineering for chemical engineering, and offers a promising platform for the inexperienced and environmental use of biofuels.

Resolving the formidable barrier of oxygen transferring rate (OTR) in ultrahigh-titer bioconversion/biocatalysis by a sealed-oxygen supply biotechnology (SOS).
Resolving the formidable barrier of oxygen transferring price (OTR) in ultrahigh-titer bioconversion/biocatalysis by a sealed-oxygen provide biotechnology (SOS).

Panel 1: Biotechnology, biomedical engineering and new fashions of otitis media.

To summarize not too long ago revealed key articles on the matters of biomedical engineering, biotechnology and new fashions in relation to otitis media (OM).Digital databases: PubMed, Ovid Medline, Cochrane Library and Scientific Proof (BMJ Publishing).Articles on biomedical engineering, biotechnology, materials science, mechanical and animal fashions in OM revealed between Might 2015 and Might 2019 have been recognized and subjected to overview. A complete of 132 articles have been finally included.

EGFR Antibody

23630 100ul
EUR 319

EGFR Antibody

23630-100ul 100ul
EUR 468

EGFR antibody

20-ES04 250 ug
EUR 478
Description: Sheep polyclonal EGFR antibody

EGFR antibody

10R-E101a 250 ug
EUR 989
Description: Mouse monoclonal EGFR antibody

EGFR antibody

20R-1723 100 ug
EUR 807.6
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-1940 50 ug
EUR 269
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-1941 50 ug
EUR 269
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2032 50 ug
EUR 269
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2033 50 ug
EUR 269
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2062 50 ug
EUR 269
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2068 50 ug
EUR 269
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2069 50 ug
EUR 269
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2096 50 ug
EUR 269
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2177 50 ug
EUR 269
Description: Goat polyclonal EGFR antibody

EGFR antibody

20R-2254 50 ug
EUR 269
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2255 50 ug
EUR 269
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2356 50 ug
EUR 269
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2357 50 ug
EUR 269
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2376 50 ug
EUR 269
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2384 50 ug
EUR 269
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2385 50 ug
EUR 269
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2414 50 ug
EUR 269
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2688 50 ug
EUR 269
Description: Goat polyclonal EGFR antibody

EGFR antibody

20R-2968 100 ul
EUR 471.6
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-ER004 250 µL
EUR 719
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-ER022 50 ug
EUR 709
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-ER023 50 ug
EUR 709
Description: Rabbit polyclonal EGFR antibody

EGFR Antibody

48691 100ul
EUR 499

EGFR Antibody

48691-100ul 100ul
EUR 399.6

EGFR Antibody

48691-50ul 50ul
EUR 286.8

EGFR Antibody

48714 100ul
EUR 499

EGFR Antibody

48714-100ul 100ul
EUR 399.6

EGFR Antibody

48714-50ul 50ul
EUR 286.8

EGFR Antibody

MBS7136494-005mL 0.05mL
EUR 220

EGFR Antibody

MBS7136494-01mL 0.1mL
EUR 300

EGFR Antibody

MBS7136494-5x01mL 5x0.1mL
EUR 1350

EGFR Antibody

MBS7136740-005mL 0.05mL
EUR 220

EGFR Antibody

MBS7136740-01mL 0.1mL
EUR 300

EGFR Antibody

MBS7136740-5x01mL 5x0.1mL
EUR 1350

EGFR Antibody

MBS7118155-005mg 0.05mg
EUR 150

EGFR Antibody

MBS7118155-01mg 0.1mg
EUR 190

EGFR Antibody

MBS7118155-5x01mg 5x0.1mg
EUR 845

EGFR Antibody

MBS7118156-005mg 0.05mg
EUR 150

EGFR Antibody

MBS7118156-01mg 0.1mg
EUR 190

EGFR Antibody

MBS7118156-5x01mg 5x0.1mg
EUR 845

EGFR Antibody

MBS7118157-005mg 0.05mg
EUR 150

EGFR Antibody

MBS7118157-01mg 0.1mg
EUR 190

EGFR Antibody

MBS7118157-5x01mg 5x0.1mg
EUR 845

EGFR Antibody

MBS7121981-005mg 0.05mg
EUR 150

EGFR Antibody

MBS7121981-01mg 0.1mg
EUR 190

EGFR Antibody

MBS7121981-5x01mg 5x0.1mg
EUR 845

EGFR Antibody

MBS7121982-005mg 0.05mg
EUR 150

EGFR Antibody

MBS7121982-01mg 0.1mg
EUR 190

EGFR Antibody

MBS7121982-5x01mg 5x0.1mg
EUR 845

EGFR Antibody

MBS7122479-005mg 0.05mg
EUR 150

EGFR Antibody

MBS7122479-01mg 0.1mg
EUR 190

EGFR Antibody

MBS7122479-5x01mg 5x0.1mg
EUR 845

EGFR Antibody

MBS7122480-005mg 0.05mg
EUR 150

EGFR Antibody

MBS7122480-01mg 0.1mg
EUR 190

EGFR Antibody

MBS7122480-5x01mg 5x0.1mg
EUR 845

EGFR Antibody

MBS7116274-005mg 0.05mg
EUR 150

EGFR Antibody

MBS7116274-01mg 0.1mg
EUR 190

EGFR Antibody

MBS7116274-5x01mg 5x0.1mg
EUR 845

EGFR Antibody

MBS7116275-005mg 0.05mg
EUR 150

EGFR Antibody

MBS7116275-01mg 0.1mg
EUR 190

EGFR Antibody

MBS7116275-5x01mg 5x0.1mg
EUR 845

EGFR Antibody

MBS7116276-005mg 0.05mg
EUR 150

EGFR Antibody

MBS7116276-01mg 0.1mg
EUR 190

EGFR Antibody

MBS7116276-5x01mg 5x0.1mg
EUR 845

EGFR Antibody

MBS7127098-005mL 0.05mL
EUR 190

EGFR Antibody

MBS7127098-01mL 0.1mL
EUR 270

EGFR Antibody

MBS7127098-5x01mL 5x0.1mL
EUR 1205

EGFR antibody

70R-34091 100 ug
EUR 294
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-34093 100 ug
EUR 294
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-34095 100 ug
EUR 294
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-34097 100 ug
EUR 294
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-34099 100 ug
EUR 294
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-34101 100 ug
EUR 294
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-35670 100 ug
EUR 294
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-37513 100 ug
EUR 260
Description: Rabbit Polyclonal EGFR antibody

EGFR antibody

70R-37514 100 ug
EUR 260
Description: Rabbit Polyclonal EGFR antibody

EGFR antibody

70R-49690 100 ul
EUR 286
Description: Purified Polyclonal EGFR antibody

EGFR antibody

70R-49691 100 ul
EUR 242
Description: Purified Polyclonal EGFR antibody

EGFR antibody

70R-51525 100 ul
EUR 286
Description: Purified Polyclonal EGFR antibody

EGFR antibody

70R-51526 100 ul
EUR 242
Description: Purified Polyclonal EGFR antibody

EGFR antibody

70R-30569 100 ug
EUR 294
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-30571 100 ug
EUR 294
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-31553 100 ug
EUR 294
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-33569 100 ug
EUR 294
Description: Rabbit polyclonal EGFR antibody

EGFR Antibody

3782-100 each
EUR 405.6

EGFR Antibody

36836 100ul
EUR 319

EGFR Antibody

36836-100ul 100ul
EUR 302.4

EGFR antibody

38493-100ul 100ul
EUR 302.4

EGFR Antibody

MBS7104097-005mg 0.05mg
EUR 190

EGFR Antibody

MBS7104097-01mg 0.1mg
EUR 270

EGFR Antibody

MBS7104097-5x01mg 5x0.1mg
EUR 1205

EGFR Antibody

E18-6042-1 50μg/50μl
EUR 145
Description: Available in various conjugation types.

EGFR Antibody

E18-6042-2 100μg/100μl
EUR 225
Description: Available in various conjugation types.

EGFR Antibody

E18-6043-1 50μg/50μl
EUR 145
Description: Available in various conjugation types.

EGFR Antibody

E18-6043-2 100μg/100μl
EUR 225
Description: Available in various conjugation types.

EGFR Antibody

E18-6052-1 50μg/50μl
EUR 145
Description: Available in various conjugation types.

EGFR Antibody

E18-6052-2 100μg/100μl
EUR 225
Description: Available in various conjugation types.

EGFR Antibody

E18-0436-1 50μg/50μl
EUR 145
Description: Available in various conjugation types.

EGFR Antibody

E18-0436-2 100μg/100μl
EUR 225
Description: Available in various conjugation types.

EGFR Antibody

E11-10257C 100μg
EUR 225
Description: Available in various conjugation types.

EGFR Antibody

E10-30551 100ul
EUR 225
Description: Available in various conjugation types.

EGFR Antibody

E10-30552 100ul
EUR 225
Description: Available in various conjugation types.

EGFR Antibody

E19-7105 100μg/100μl
EUR 225
Description: Available in various conjugation types.

EGFR Antibody

E036836 100μg/100μl
EUR 255
Description: Available in various conjugation types.

EGFR Antibody

K49030M01G01C-100ug 100 ug
EUR 360
Description: Monoclonal Antibody

EGFR Antibody

K49030M01G01C-1mg 1 mg
EUR 1800
Description: Monoclonal Antibody

EGFR Antibody

K49030M01G01C-50ug 50 ug
EUR 252
Description: Monoclonal Antibody

EGFR Antibody

K49030M01H05C-100ug 100 ug
EUR 440
Description: Monoclonal Antibody

EGFR Antibody

K49030M01H05C-1mg 1 mg
EUR 2200
Description: Monoclonal Antibody

EGFR Antibody

K49030M01H05C-50ug 50 ug
EUR 308
Description: Monoclonal Antibody

EGFR Antibody

K49030M01H11C-100ug 100 ug
EUR 440
Description: Monoclonal Antibody

EGFR Antibody

K49030M01H11C-1mg 1 mg
EUR 2200
Description: Monoclonal Antibody

EGFR Antibody

K49030M01H11C-50ug 50 ug
EUR 308
Description: Monoclonal Antibody

EGFR Antibody

B8024-100ul 100μl
EUR 217
Description: EGFR Rabbit Polyclonal Antibody

EGFR Antibody

B8024-50ul 50μl
EUR 143.5
Description: EGFR Rabbit Polyclonal Antibody

EGFR Antibody

B8025-100ul 100μl
EUR 217
Description: EGFR Rabbit Polyclonal Antibody

EGFR Antibody

B8025-50ul 50μl
EUR 143.5
Description: EGFR Rabbit Polyclonal Antibody

EGFR Antibody

B8026-100ul 100μl
EUR 217
Description: EGFR Rabbit Polyclonal Antibody

New imaging applied sciences for the tympanic membrane (TM) and the center ear cavity are being developed to evaluate TM thickness, establish biofilms and differentiate kinds of center ear effusions. Synthetic intelligence (AI) has been utilized to coach software program applications to diagnose OM with a excessive diploma of certainty. Genetically modified mice fashions for OM have additional investigated what predisposes some people to OM and consequent listening to loss. New vaccine candidates defending in opposition to main otopathogens are being explored and developed, particularly mixed vaccines, concentrating on multiple pathogen.

Transcutaneous vaccination in opposition to non-typeable Haemophilus influenzae has been efficiently tried in a chinchilla mannequin. When it comes to remedy, novel applied sciences for trans-tympanic drug supply are getting into the scientific area. Varied development components and grafting supplies geared toward enhancing therapeutic of TM perforations present promising leads to animal fashions.

New applied sciences and AI purposes to enhance the analysis of OM have proven promise in pre-clinical fashions and are steadily getting into the scientific area. So are novel vaccines and drug supply approaches that will permit native remedy of OM.New diagnostic strategies, potential vaccine candidates and the novel trans-tympanic drug supply present promising outcomes, however are usually not but tailored to scientific use.

Growing a circular economy with fungal biotechnology: a white paper.

Growing a circular economy with fungal biotechnology: a white paper.

Fungi have the power to remodel natural supplies right into a wealthy and various set of helpful merchandise and supply distinct alternatives for tackling the pressing challenges earlier than all people. Fungal biotechnology can advance the transition from our petroleum-based financial system right into a bio-based round financial system and has the power to sustainably produce resilient sources of meals, feed, chemical compounds, fuels, textiles, and supplies for building, automotive and transportation industries, for furnishings and past.

Fungal biotechnology affords options for securing, stabilizing and enhancing the meals provide for a rising human inhabitants, whereas concurrently reducing greenhouse gasoline emissions.

Fungal biotechnology has, thus, the potential to make a big contribution to local weather change mitigation and assembly the United Nation’s sustainable growth objectives by means of the rational enchancment of latest and established fungal cell factories.

The White Paper offered right here is the results of the 2nd Assume Tank assembly held by the EUROFUNG consortium in Berlin in October 2019. This paper highlights discussions on present alternatives and analysis challenges in fungal biotechnology and goals to tell scientists, educators, most people, industrial stakeholders and policymakers in regards to the present fungal biotech revolution.

 Growing a circular economy with fungal biotechnology: a white paper.
Rising a round financial system with fungal biotechnology: a white paper.

The Integration and Harmonisation of Secular and Islamic Moral Ideas in Formulating Acceptable Moral Pointers for Trendy Biotechnology in Malaysia.

The Malaysian authorities recognises the potential contribution of biotechnology to the nationwide financial system. Nonetheless, ongoing controversy persists relating to its moral standing and no particular moral pointers have been printed referring to its use. In creating such pointers, you will need to establish the underlying rules which might be acceptable to Malaysian society. This paper discusses the method of figuring out related secular and Islamic moral rules and establishing their similarities earlier than harmonising them.

OACD03186-100UL - EGFR2 Antibody

OACD03186-100UL 100ul
EUR 199

Active Epidermal Growth Factor Receptor 2 (EGFR2)

4-APB867Hu01
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 5 mg
  • 10ug
  • 50ug
  • 100 ug
  • 200 ug
  • 500 ug
  • 1 mg
Description: Recombinant Human Epidermal Growth Factor Receptor 2 expressed in: Available from E.coli, Yeast, Baculovirus and Mammalian cells

Active Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2105153-001mg 0.01mg
EUR 230

Active Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2105153-005mg 0.05mg
EUR 470

Active Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2105153-01mg 0.1mg
EUR 715

Active Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2105153-02mg 0.2mg
EUR 885

Active Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2105153-05mg 0.5mg
EUR 1715

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx176304
  • Ask for price
  • Ask for price
  • 200 ug
  • 1 mg

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx172273
  • Ask for price
  • Ask for price
  • 200 ug
  • 1 mg

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx130837
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx103702
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx103703
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 20 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx103704
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx128593
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2011286-001mg 0.01mg
EUR 170

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2011286-005mg 0.05mg
EUR 305

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2011286-01mg 0.1mg
EUR 460

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2011286-02mg 0.2mg
EUR 560

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2011286-05mg 0.5mg
EUR 1065

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2011616-001mg 0.01mg
EUR 165

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2011616-005mg 0.05mg
EUR 285

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2011616-01mg 0.1mg
EUR 425

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2011616-02mg 0.2mg
EUR 515

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2011616-05mg 0.5mg
EUR 980

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2033400-001mg 0.01mg
EUR 165

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2033400-005mg 0.05mg
EUR 285

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2033400-01mg 0.1mg
EUR 425

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2033400-02mg 0.2mg
EUR 515

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2033400-05mg 0.5mg
EUR 980

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2029031-001mg 0.01mg
EUR 170

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2029031-005mg 0.05mg
EUR 300

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2029031-01mg 0.1mg
EUR 460

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2029031-02mg 0.2mg
EUR 560

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

MBS2029031-05mg 0.5mg
EUR 1065

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

4-RPB867Hu01
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 5 mg
  • 10ug
  • 50ug
  • 100 ug
  • 200 ug
  • 500 ug
  • 1 mg
Description: Recombinant Human Epidermal Growth Factor Receptor 2 expressed in: E.coli

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

4-RPB867Hu02
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 5 mg
  • 10ug
  • 50ug
  • 100 ug
  • 200 ug
  • 500 ug
  • 1 mg
Description: Recombinant Human Epidermal Growth Factor Receptor 2 expressed in: E.coli

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

4-RPB867Mu01
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 5 mg
  • 10ug
  • 50ug
  • 100 ug
  • 200 ug
  • 500 ug
  • 1 mg
Description: Recombinant Mouse Epidermal Growth Factor Receptor 2 expressed in: E.coli

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

4-RPB867Ra01
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 5 mg
  • 10ug
  • 50ug
  • 100 ug
  • 200 ug
  • 500 ug
  • 1 mg
Description: Recombinant Rat Epidermal Growth Factor Receptor 2 expressed in: E.coli

Rat Epidermal Growth Factor Receptor 2 (EGFR2) Protein

20-abx066445
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Human Epidermal Growth Factor Receptor 2 (EGFR2) Protein

20-abx168780
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Human Epidermal Growth Factor Receptor 2 (EGFR2) Protein

20-abx066444
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) Protein

20-abx066447
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody (FITC)

20-abx271123
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody (FITC)

20-abx271195
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody (Biotin)

20-abx271389
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody (Biotin)

20-abx271461
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody

MBS2032476-01mL 0.1mL
EUR 170

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody

MBS2032476-02mL 0.2mL
EUR 205

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody

MBS2032476-05mL 0.5mL
EUR 335

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody

MBS2032476-1mL 1mL
EUR 415

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody

MBS2032476-5mL 5mL
EUR 1130

Pig Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

abx361560-96tests 96 tests
EUR 904.8

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

20-abx155460
  • Ask for price
  • Ask for price
  • Ask for price
  • 96 tests
  • 5 × 96 tests
  • 10 × 96 tests

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DLR-EGFR2-Ra 96T
EUR 417
Description: serum, plasma or other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DLR-EGFR2-Ra-48T 48T
EUR 570
Description: A sandwich quantitative ELISA assay kit for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in samples from serum, plasma or other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DLR-EGFR2-Ra-96T 96T
EUR 739.2
Description: A sandwich quantitative ELISA assay kit for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in samples from serum, plasma or other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

EK13780 96Т
EUR 768

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

EKL54233-5x96T 5x96T
EUR 3250.43

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

EKL54233-96T 96T
EUR 684.3

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DL-EGFR2-Ra 96T
EUR 397
Description: serum, plasma or other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2703824-10x96StripWells 10x96-Strip-Wells
EUR 3225

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2703824-24StripWells 24-Strip-Wells
EUR 255

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2703824-48StripWells 48-Strip-Wells
EUR 340

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2703824-5x96StripWells 5x96-Strip-Wells
EUR 1680

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2703824-96StripWells 96-Strip-Wells
EUR 430

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2022437-10x96StripWells 10x96-Strip-Wells
EUR 5470

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2022437-24StripWells 24-Strip-Wells
EUR 365

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2022437-48StripWells 48-Strip-Wells
EUR 555

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2022437-5x96StripWells 5x96-Strip-Wells
EUR 2995

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2022437-96StripWells 96-Strip-Wells
EUR 740

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS452401-10x96StripWells 10x96-Strip-Wells
EUR 4660

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS452401-48StripWells 48-Strip-Wells
EUR 410

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS452401-5x96StripWells 5x96-Strip-Wells
EUR 2390

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS452401-96StripWells 96-Strip-Wells
EUR 540

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS459010-10x96Tests 10x96Tests
EUR 4845

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS459010-48Tests 48Tests
EUR 425

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS459010-5x96Tests 5x96Tests
EUR 2490

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS459010-96Tests 96Tests
EUR 555

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2606897-10x96StripWells 10x96-Strip-Wells
EUR 3290

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2606897-48StripWells 48-Strip-Wells
EUR 295

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2606897-5x96StripWells 5x96-Strip-Wells
EUR 1800

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2606897-96StripWells 96-Strip-Wells
EUR 450

Rat EGFR2 (Epidermal Growth Factor Receptor 2) ELISA Kit

MBS8804762-10x96StripWells 10x96-Strip-Wells
EUR 3130

Rat EGFR2 (Epidermal Growth Factor Receptor 2) ELISA Kit

MBS8804762-48StripWells 48-Strip-Wells
EUR 350

Rat EGFR2 (Epidermal Growth Factor Receptor 2) ELISA Kit

MBS8804762-5x96StripWells 5x96-Strip-Wells
EUR 1710

Rat EGFR2 (Epidermal Growth Factor Receptor 2) ELISA Kit

MBS8804762-96StripWells 96-Strip-Wells
EUR 445

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Ra-10x96wellstestplate 10x96-wells test plate
EUR 5850.59
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma and other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Ra-1x48wellstestplate 1x48-wells test plate
EUR 586.99
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma and other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Ra-1x96wellstestplate 1x96-wells test plate
EUR 787.13
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma and other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Ra-5x96wellstestplate 5x96-wells test plate
EUR 3182.08
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma and other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

4-SEB867Ra
  • Ask for price
  • Ask for price
  • Ask for price
  • 1 plate of 96 wells
  • 5 plates of 96 wells
  • 10 plates of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in samples from Serum, plasma and other biological fluids. with no significant corss-reactivity with analogues from other species.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RDR-EGFR2-Ra-48T 48T
EUR 448
Description: sandwich

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RDR-EGFR2-Ra-48Tests 48 Tests
EUR 594

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RDR-EGFR2-Ra-96T 96T
EUR 641
Description: sandwich

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RDR-EGFR2-Ra-96Tests 96 Tests
EUR 822

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RD-EGFR2-Ra-48T 48T
EUR 427
Description: sandwich

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RD-EGFR2-Ra-48Tests 48 Tests
EUR 567.6

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RD-EGFR2-Ra-96T 96T
EUR 610
Description: sandwich

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RD-EGFR2-Ra-96Tests 96 Tests
EUR 786

Human EGFR2 -Epidermal Growth Factor Receptor 2- CLIA Kit

E-CL-H1044-24Tests 24 Tests
EUR 180
Description: Sandwich

Human EGFR2 -Epidermal Growth Factor Receptor 2- CLIA Kit

E-CL-H1044-48Tests 48 Tests
EUR 546
Description: Sandwich

Human EGFR2 -Epidermal Growth Factor Receptor 2- CLIA Kit

E-CL-H1044-96Tests 96 Tests
EUR 682
Description: Sandwich

Human EGFR2 -Epidermal Growth Factor Receptor 2- CLIA Kit

E-CL-H1044-96Tests10 96 Tests *10
EUR 6820
Description: Sandwich

Human EGFR2 -Epidermal Growth Factor Receptor 2- CLIA Kit

E-CL-H1044-96Tests5 96 Tests *5
EUR 3410
Description: Sandwich

Goat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2605726-10x96StripWells 10x96-Strip-Wells
EUR 3545

Goat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2605726-48StripWells 48-Strip-Wells
EUR 310

Goat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2605726-5x96StripWells 5x96-Strip-Wells
EUR 1940

Goat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2605726-96StripWells 96-Strip-Wells
EUR 475

Human EGFR2 (Epidermal Growth Factor Receptor 2) CLIA Kit

MBS2530461-5x96Tests 5x96Tests
EUR 2565

Human EGFR2 (Epidermal Growth Factor Receptor 2) CLIA Kit

MBS2530461-96Tests 96Tests
EUR 560

Human Epidermal Growth Factor Receptor 2 (EGFR2)ELISA Kit

201-12-2674 96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

abx573464-96tests 96 tests
EUR 848.4

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

abx573292-96tests 96 tests
EUR 943.2

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DLR-EGFR2-Hu 96T
EUR 383
Description: serum, plasma, tissue homogenates or other biological fluids.

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DLR-EGFR2-Hu-48T 48T
EUR 532.8
Description: A sandwich quantitative ELISA assay kit for detection of Human Epidermal Growth Factor Receptor 2 (EGFR2) in samples from serum, plasma, tissue homogenates or other biological fluids.

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DLR-EGFR2-Hu-96T 96T
EUR 687.6
Description: A sandwich quantitative ELISA assay kit for detection of Human Epidermal Growth Factor Receptor 2 (EGFR2) in samples from serum, plasma, tissue homogenates or other biological fluids.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DLR-EGFR2-Mu 96T
EUR 394
Description: serum, plasma, tissue homogenates or other biological fluids.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DLR-EGFR2-Mu-48T 48T
EUR 544.8
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Epidermal Growth Factor Receptor 2 (EGFR2) in samples from serum, plasma, tissue homogenates or other biological fluids.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DLR-EGFR2-Mu-96T 96T
EUR 704.4
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Epidermal Growth Factor Receptor 2 (EGFR2) in samples from serum, plasma, tissue homogenates or other biological fluids.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

EK13779 96Т
EUR 768

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

EKL54231-5x96T 5x96T
EUR 2984.43

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

EKL54231-96T 96T
EUR 628.3

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

EKL54232-5x96T 5x96T
EUR 3075.15

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

EKL54232-96T 96T
EUR 647.4

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

EKL56960-5x96T 5x96T
EUR 3133.58

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

EKL56960-96T 96T
EUR 659.7

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

EIA07563h each
EUR 430

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DL-EGFR2-Hu 96T
EUR 365
Description: serum, plasma, tissue homogenates or other biological fluids.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DL-EGFR2-Mu 96T
EUR 375
Description: serum, plasma, tissue homogenates or other biological fluids.

Human EGFR2(Epidermal Growth Factor Receptor 2) ELISA Kit

EH2981 96T
EUR 628.92
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 75pg/ml

Human EGFR2 (Epidermal Growth Factor Receptor 2) ELISA Kit

MBS2501726-10x96Tests 10x96Tests
EUR 4060

Human EGFR2 (Epidermal Growth Factor Receptor 2) ELISA Kit

MBS2501726-24Tests 24Tests
EUR 265

Human EGFR2 (Epidermal Growth Factor Receptor 2) ELISA Kit

MBS2501726-48Tests 48Tests
EUR 450

Human EGFR2 (Epidermal Growth Factor Receptor 2) ELISA Kit

MBS2501726-5x96Tests 5x96Tests
EUR 2265

Human EGFR2 (Epidermal Growth Factor Receptor 2) ELISA Kit

MBS2501726-96Tests 96Tests
EUR 535

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2703822-10x96StripWells 10x96-Strip-Wells
EUR 2980

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2703822-24StripWells 24-Strip-Wells
EUR 245

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2703822-48StripWells 48-Strip-Wells
EUR 325

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2703822-5x96StripWells 5x96-Strip-Wells
EUR 1555

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2703822-96StripWells 96-Strip-Wells
EUR 395

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2703823-10x96StripWells 10x96-Strip-Wells
EUR 3060

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2703823-24StripWells 24-Strip-Wells
EUR 250

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2703823-48StripWells 48-Strip-Wells
EUR 325

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2703823-5x96StripWells 5x96-Strip-Wells
EUR 1595

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2703823-96StripWells 96-Strip-Wells
EUR 410

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2021836-10x96StripWells 10x96-Strip-Wells
EUR 5100

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2021836-24StripWells 24-Strip-Wells
EUR 350

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2021836-48StripWells 48-Strip-Wells
EUR 520

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2021836-5x96StripWells 5x96-Strip-Wells
EUR 2795

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2021836-96StripWells 96-Strip-Wells
EUR 695

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2023152-10x96StripWells 10x96-Strip-Wells
EUR 5220

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2023152-24StripWells 24-Strip-Wells
EUR 355

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2023152-48StripWells 48-Strip-Wells
EUR 535

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2023152-5x96StripWells 5x96-Strip-Wells
EUR 2860

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2023152-96StripWells 96-Strip-Wells
EUR 705

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS459008-10x96Tests 10x96Tests
EUR 4520

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS459008-48Tests 48Tests
EUR 390

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS459008-5x96Tests 5x96Tests
EUR 2320

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS459008-96Tests 96Tests
EUR 525

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS459009-10x96Tests 10x96Tests
EUR 4630

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS459009-48Tests 48Tests
EUR 405

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS459009-5x96Tests 5x96Tests
EUR 2375

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS459009-96Tests 96Tests
EUR 535

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS455288-10x96StripWells 10x96-Strip-Wells
EUR 4350

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS455288-48StripWells 48-Strip-Wells
EUR 380

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS455288-5x96StripWells 5x96-Strip-Wells
EUR 2230

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS455288-96StripWells 96-Strip-Wells
EUR 505

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS455727-10x96StripWells 10x96-Strip-Wells
EUR 4450

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS455727-48StripWells 48-Strip-Wells
EUR 390

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS455727-5x96StripWells 5x96-Strip-Wells
EUR 2285

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS455727-96StripWells 96-Strip-Wells
EUR 515

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2604145-10x96StripWells 10x96-Strip-Wells
EUR 3040

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2604145-48StripWells 48-Strip-Wells
EUR 285

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2604145-5x96StripWells 5x96-Strip-Wells
EUR 1670

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2604145-96StripWells 96-Strip-Wells
EUR 405

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2606425-10x96StripWells 10x96-Strip-Wells
EUR 3290

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2606425-48StripWells 48-Strip-Wells
EUR 295

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2606425-5x96StripWells 5x96-Strip-Wells
EUR 1800

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

MBS2606425-96StripWells 96-Strip-Wells
EUR 450

To attain this, a sequence of focus group discussions had been performed with 23 information consultants representing varied stakeholders within the biotechnology neighborhood. Notably, a number of rules between the secular and Islamic views are not directly or straight related.

All of the consultants agreed with the predominant six moral rules of secular and Islamic philosophy and their significance and relevance in trendy biotechnology.

These are beneficence and non-maleficence as the primary or overarching rules, the preservation of spiritual and ethical values, the preservation of the mind and the thoughts, the safety of human security, the safety of future generations, and safety of the surroundings and organic range. A number of changes had been made to the terminologies and definitions of those six rules to formulate acceptable guiding rules for the ethics of contemporary biotechnology in Malaysia.

These can then be adopted as core values to underpin future nationwide pointers on trendy biotechnology ethics. These rules can be notably essential in guiding the coverage makers, enforcers, industries and researchers to streamline their actions. In so doing, trendy biotechnology and its merchandise might be correctly managed with out jeopardising the pursuits of the Muslim neighborhood in addition to most people.

Importantly, they’re expansive and inclusive sufficient to embrace the non secular sensitivity of various quarters of Malaysia.